Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Division of Cardiology and National Institute for Prevention and Cardiovascular Health, National University of Ireland, Galway, Ireland.
Diabetes Care. 2020 Feb;43(2):382-388. doi: 10.2337/dc19-1221. Epub 2019 Nov 27.
Diabetes in older age is heterogeneous, and the treatment approach varies by patient characteristics. We characterized the short-term all-cause and cardiovascular mortality risk associated with hyperglycemia in older age.
We included 5,791 older adults in the Atherosclerosis Risk in Communities Study who attended visit 5 (2011-2013; ages 66-90 years). We compared prediabetes (HbA 5.7% to <6.5%), newly diagnosed diabetes (HbA ≥6.5%, prior diagnosis <1 year, or taking antihyperglycemic medications <1 year), short-duration diabetes (duration ≥1 year but <10 years [median]), and long-standing diabetes (duration ≥10 years). Outcomes were all-cause and cardiovascular mortality (median follow-up of 5.6 years).
Participants were 58% female, and 24% had prevalent cardiovascular disease. All-cause mortality rates, per 1,000 person-years, were 21.2 (95% CI 18.7, 24.1) among those without diabetes, 23.7 (95% CI 20.8, 27.1) for those with prediabetes, 33.8 (95% CI 25.2, 45.5) among those with recently diagnosed diabetes, 29.6 (95% CI 25.0, 35.1) for those with diabetes of short duration, and 48.6 (95% CI 42.4, 55.7) for those with long-standing diabetes. Cardiovascular mortality rates, per 1,000 person-years, were 5.8 (95% CI 4.6, 7.4) among those without diabetes, 6.6 (95% CI 5.2, 8.5) for those with prediabetes, 11.5 (95% CI 7.0, 19.1) among those with recently diagnosed diabetes, 8.2 (95% CI 5.9, 11.3) for those with diabetes of short duration, and 17.3 (95% CI 13.8, 21.7) for those with long-standing diabetes. After adjustment for other cardiovascular risk factors, prediabetes and newly diagnosed diabetes were not significantly associated with a higher risk of all-cause mortality (hazard ratio [HR] 1.03 [95% CI 0.85, 1.23] and HR 1.31 [95% CI 0.94, 1.82], respectively) or cardiovascular mortality (HR 1.00 [95% CI 0.70, 1.43] and HR 1.35 [95% CI 0.74, 2.49], respectively). Excess mortality risk was primarily concentrated among those with long-standing diabetes (all-cause: HR 1.71 [95% CI 1.40, 2.10]; cardiovascular: HR 1.72 [95% CI 1.18, 2.51]).
In older adults, long-standing diabetes has a substantial and independent effect on short-term mortality. Older individuals with prediabetes remained at low mortality risk over a median 5.6 years of follow-up.
老年糖尿病具有异质性,其治疗方法因患者特征而异。本研究旨在描述老年人群中与高血糖相关的短期全因和心血管死亡率风险。
我们纳入了参加社区动脉粥样硬化风险研究第 5 次访视(2011-2013 年;年龄 66-90 岁)的 5791 名老年人。我们比较了以下情况:糖尿病前期(HbA1c 为 5.7%至<6.5%)、新诊断的糖尿病(HbA1c ≥6.5%,既往诊断时间<1 年或<1 年内开始使用抗高血糖药物)、短期糖尿病(病程≥1 年但<10 年[中位数])和长期糖尿病(病程≥10 年)。结局为全因和心血管死亡率(中位随访时间为 5.6 年)。
参与者中 58%为女性,24%患有心血管疾病。无糖尿病患者的全因死亡率(每 1000 人年)为 21.2(95%CI 18.7,24.1),糖尿病前期患者为 23.7(95%CI 20.8,27.1),新诊断的糖尿病患者为 33.8(95%CI 25.2,45.5),病程较短的糖尿病患者为 29.6(95%CI 25.0,35.1),病程较长的糖尿病患者为 48.6(95%CI 42.4,55.7)。无糖尿病患者的心血管死亡率(每 1000 人年)为 5.8(95%CI 4.6,7.4),糖尿病前期患者为 6.6(95%CI 5.2,8.5),新诊断的糖尿病患者为 11.5(95%CI 7.0,19.1),病程较短的糖尿病患者为 8.2(95%CI 5.9,11.3),病程较长的糖尿病患者为 17.3(95%CI 13.8,21.7)。在校正其他心血管危险因素后,糖尿病前期和新诊断的糖尿病与全因死亡率(风险比 [HR] 1.03[95%CI 0.85,1.23]和 HR 1.31[95%CI 0.94,1.82])或心血管死亡率(HR 1.00[95%CI 0.70,1.43]和 HR 1.35[95%CI 0.74,2.49])的升高无显著相关性。过度死亡风险主要集中在病程较长的糖尿病患者中(全因:HR 1.71[95%CI 1.40,2.10];心血管:HR 1.72[95%CI 1.18,2.51])。
在老年人中,长期糖尿病对短期死亡率有显著的独立影响。中位随访 5.6 年期间,患有糖尿病前期的老年人死亡率仍保持在较低水平。